Cormorant Asset Management’s Acceleron Pharma XLRN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q3 | – | Sell |
|
|||||
|
2021
Q2 | $22M | Sell |
|
|||||
|
2021
Q1 | $37.3M | Sell |
|
|||||
|
2020
Q4 | $54.4M | Sell |
|
|||||
|
2020
Q3 | $56.3M | Sell |
|
|||||
|
2020
Q2 | $57.2M | Sell |
|
|||||
|
2020
Q1 | $74.1M | Buy |
|
|||||
|
2019
Q4 | – | Sell |
|
|||||
|
2019
Q3 | $988K | Sell |
|
|||||
|
2019
Q2 | $1.64M | Hold |
|
|||||
|
2019
Q1 | $1.86M | Sell |
|
|||||
|
2018
Q4 | $2.12M | Sell |
|
|||||
|
2018
Q3 | $2.86M | Sell |
|
|||||
|
2018
Q2 | $3.48M | Hold |
|
|||||
|
2018
Q1 | $2.8M | Sell |
|
|||||
|
2017
Q4 | $3.18M | Hold |
|
|||||
|
2017
Q3 | $2.8M | Hold |
|
|||||
|
2017
Q2 | $2.28M | Hold |
|
|||||
|
2017
Q1 | $1.99M | Sell |
|
|||||
|
2016
Q4 | $3.25M | Hold |
|
|||||
|
2016
Q3 | $4.61M | Hold |
|
|||||
|
2016
Q2 | $4.33M | Sell |
|
|||||
|
2016
Q1 | $5.28M | Hold |
|
|||||
|
2015
Q4 | $9.75M | Hold |
|
|||||
|
2015
Q3 | $4.98M | Hold |
|
|||||
|
2015
Q2 | $6.33M | Buy |
|
|||||
|
2015
Q1 | $6.47M | Sell |
|
|||||
|
2014
Q4 | $9.74M | Sell |
|
|||||
|
2014
Q3 | $12.1M | Buy |
|
|||||
|
2014
Q2 | $6.79M | Buy |
|